SAN DIEGO, Sept. 26, 2011 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange (4875), today announced the appointment of Mr. Tatsuo Izumi to its Board of Directors.
